Detalhe da pesquisa
1.
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease.
N Engl J Med
; 384(3): 205-215, 2021 01 21.
Artigo
Inglês
| MEDLINE | ID: mdl-33283990
2.
Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of ß-Hemoglobinopathies.
Mol Ther
; 26(2): 480-495, 2018 02 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29221807
3.
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy.
Cytotherapy
; 20(7): 952-963, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30180944
4.
A clinical trial combining megakaryocytes and haematopoietic stem cells to promote engraftment after autologous transplantation.
Br J Haematol
; 183(1): 139-142, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28891211
5.
Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations.
Front Immunol
; 14: 1280826, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38077331
6.
Cultivated autologous limbal epithelial cell (CALEC) transplantation: Development of manufacturing process and clinical evaluation of feasibility and safety.
Sci Adv
; 9(33): eadg6470, 2023 08 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37595035
7.
Lymphodepletion - an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle.
Front Immunol
; 14: 1303935, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38187393
8.
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies.
MAbs
; 15(1): 2211692, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37184206
9.
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models.
J Immunother Cancer
; 10(5)2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35577500
10.
Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHD.
Biol Blood Marrow Transplant
; 17(2): 265-9, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20691799
11.
Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation.
Transfusion
; 51(8): 1769-78, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21332732
12.
Delayed recovery after autologous peripheral hematopoietic cell transplantation: potential effect of a high number of total nucleated cells in the graft.
Transfusion
; 50(12): 2649-59, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-20576009
13.
Global Perspective on the Development of Genetically Modified Immune Cells for Cancer Therapy.
Front Immunol
; 11: 608485, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33658994
14.
Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy.
Mol Ther Methods Clin Dev
; 17: 589-600, 2020 Jun 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32300607
15.
Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer.
Int J Oncol
; 35(3): 569-81, 2009 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-19639177
16.
Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
Arthritis Rheum
; 58(9): 2897-907, 2008 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-18759287
17.
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma.
Cancer Immunol Res
; 7(1): 100-112, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30396908
18.
Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients.
Blood Adv
; 2(19): 2505-2512, 2018 10 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30282642
19.
[Systemic lupus erythematosus: A new indication for CAR-T cell therapies?] / Lupus érythémateux disséminé - Une nouvelle indication thérapeutique pour les cellules CAR-T ?
Med Sci (Paris)
; 38(4): 337-339, 2022 04.
Artigo
Francês
| MEDLINE | ID: mdl-35485890
20.
Combination of IL-2, rapamycin, DNA methyltransferase and histone deacetylase inhibitors for the expansion of human regulatory T cells.
Oncotarget
; 8(62): 104733-104744, 2017 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29285209